About Bluesight
Bluesight is a company based in Alexandria (United States) founded in 2011 by Tim Kress-Spatz and Kevin Macdonald. Bluesight has raised $10.5 million across 2 funding rounds from investors including New Leaf Venture Partners, Thoma Bravo and Easton Capital Investment Group. The company has 115 employees as of December 31, 2022. Bluesight has completed 3 acquisitions, including Medacist, Protenus and Sectyr. Bluesight offers products and services including RFID Medication Management, KitCheck Anywhere, ControlCheck, CostCheck, and Patient Privacy Monitoring. Bluesight operates in a competitive market with competitors including HelioMetrics and DocRX, among others.
- Headquarter Alexandria, United States
- Employees 115 as on 31 Dec, 2022
- Founders Tim Kress-Spatz, Kevin Macdonald
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.5 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
New Leaf Venture Partners
& 4 more
-
Employee Count
115
as on Dec 31, 2022
-
Investments & Acquisitions
Medacist
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bluesight
Bluesight offers a comprehensive portfolio of products and services, including RFID Medication Management, KitCheck Anywhere, ControlCheck, CostCheck, and Patient Privacy Monitoring.
Automates restocking and tracking of medications in hospitals
Monitors and prevents drug diversion in healthcare settings
Modernizes retail purchasing for pharmacy operations
Optimizes drug purchasing and handles shortages compliance
Detects and manages privacy violations in healthcare data
Funding Insights of Bluesight
Bluesight has successfully raised a total of $10.5M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bluesight
Bluesight has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include New Leaf Venture Partners, Thoma Bravo and Easton Capital Investment Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Software and technology-enabled services companies are targeted for investment.
|
Locked | Locked | Locked | |
|
Stage-agnostic investments in US life sciences are managed.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Bluesight
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bluesight
Bluesight has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Medacist, Protenus and Sectyr.
Investment portfolio details for Bluesight
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cloud-based compliance solutions are provided for healthcare regulatory needs.
|
Locked | Locked | 2017 | Locked | |
|
AI-based insider threat detection and prevention solutions for healthcare sector
|
Locked | Locked | 2014 | Locked | |
|
Provider of drug diversion and dosage solutions for healthcare industry
|
Locked | Locked | 1998 | Locked |
Complete acquisition details for Bluesight
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Bluesight
Detailed financials for Bluesight
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bluesight Comparisons
Peer comparison for Bluesight
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bluesight
Bluesight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HelioMetrics and DocRX, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Offers software to detect and analyze drug diversions in healthcare settings.
|
|
| Locked | Locked | Locked |
Offers physician dispensing, medical supplies, and compliance services for healthcare.
|
Detailed competitors of Bluesight
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bluesight
Complete news archive for Bluesight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bluesight
Bluesight was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Bluesight is headquartered in Alexandria, United States.
Kevin Macdonald is the current CEO of Bluesight. They have also founded this company.
Bluesight is a funded company, having raised a total of $10.5M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Bluesight is 115.
AI-based medication data and analytics platform for pharmacies. It offers pharmaceutical intelligence and provides hospital pharmacies solutions for managing drug diversion, RFID medication monitoring, and pharmacy purchasing. They provide cloud-based software that uses data from electronic medical records and automated dispensing cabinets to proactively detect drug diversion. Additionally, they offer a practice guide for drug diversion programs and use analytics to improve drug spending and workflows.
Bluesight's top competitors include HelioMetrics and DocRX.
Bluesight offers RFID Medication Management, KitCheck Anywhere, ControlCheck, CostCheck, and Patient Privacy Monitoring.
Bluesight has 5 investors. Key investors include New Leaf Venture Partners, Thoma Bravo, Easton Capital Investment Group, Sands Capital Ventures, and LionBird.